Lisinopril And Hydrochlorothiazide
Product Images NDC 71335-1083

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 71335-1083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Lisinopril (Image 1)

Chemical structure diagram depicting the molecular components of the active ingredient, likely Lisinopril, showing various carbon rings, amino groups, carboxyl groups, and hydration as indicated by the presence of 2 water molecules (2H2O).*

FDA Label Image

Structural Formula Of Hydrochlorothiazide (Image 2)

Chemical structure diagram depicting the molecular structure of the active ingredient associated with Lisinopril and Hydrochlorothiazide by Bryant Ranch Prepack, Product NDC 71335-1083.*

FDA Label Image

Label (Lbl713351083)

Label for Lisinopril and Hydrochlorothiazide 20/25 mg tablets packaged by Bryant Ranch Prepack. The label includes a comparison to Zestoretic 20/25 mg tablets by Watson Pharma Private Limited. It indicates a bottle quantity of 30 tablets, with a storage recommendation of 20°-25°C (68°-77°F), and instructions to keep tightly closed. The NDC displayed is 71335-1083.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.